Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - AccuredReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)Gross ProfitLeasesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - AccuredReceivables - NetReceivables - OtherShares OutstandingShares Outstanding
Ratios

CollPlant Biotechnologies (CLGN) Receivables - Accured (2021 - 2025)

CollPlant Biotechnologies filings provide 5 years of Receivables - Accured readings, the most recent being -$15000.0 for Q4 2025.

  • On a quarterly basis, Receivables - Accured fell 36.36% to -$15000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$15000.0, a 36.36% decrease, with the full-year FY2025 number at -$15000.0, down 36.36% from a year prior.
  • Receivables - Accured hit -$15000.0 in Q4 2025 for CollPlant Biotechnologies, down from -$10000.0 in the prior quarter.
  • In the past five years, Receivables - Accured ranged from a high of $6000.0 in Q2 2024 to a low of -$151000.0 in Q4 2021.
  • Median Receivables - Accured over the past 5 years was -$11000.0 (2024), compared with a mean of -$34000.0.
  • Biggest five-year swings in Receivables - Accured: surged 67.82% in 2023 and later crashed 216.67% in 2025.
  • CollPlant Biotechnologies' Receivables - Accured stood at -$151000.0 in 2021, then surged by 42.38% to -$87000.0 in 2022, then surged by 67.82% to -$28000.0 in 2023, then soared by 60.71% to -$11000.0 in 2024, then tumbled by 36.36% to -$15000.0 in 2025.
  • The last three reported values for Receivables - Accured were -$15000.0 (Q4 2025), -$10000.0 (Q3 2025), and -$7000.0 (Q2 2025) per Business Quant data.